Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases—Randomized Placebo-Controlled Multicenter Trial
Background: Butyric acid’s effectiveness has not yet been assessed in the pediatric inflammatory bowel disease (IBD) population. This study aimed to evaluate the effectiveness of oral sodium butyrate as an add-on to standard therapy in children and adolescents with newly diagnosed IBD. Methods: This...
Main Authors: | Anna Pietrzak, Marcin Banasiuk, Mariusz Szczepanik, Agnieszka Borys-Iwanicka, Tomasz Pytrus, Jarosław Walkowiak, Aleksandra Banaszkiewicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/14/16/3283 |
Similar Items
-
Genetic Variants of DMBT1 and SFTPD and Disease Severity in Paediatric Inflammatory Bowel Disease—A Polish Population-Based Study
by: Aleksandra Glapa-Nowak, et al.
Published: (2021-10-01) -
Insolation and Disease Severity in Paediatric Inflammatory Bowel Disease—A Multi-Centre Cross-Sectional Study
by: Aleksandra Glapa-Nowak, et al.
Published: (2020-12-01) -
Awareness of smoking in adolescents with inflammatory bowel disease
by: Marcin Dziekiewicz, et al.
Published: (2020-03-01) -
Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity
by: Hauke Christian Tews, et al.
Published: (2023-10-01) -
Pathology of Inflammatory Bowel Disease
by: Shiva Raj K.C.
Published: (2015-03-01)